Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Dades bibliogràfiques
Autor principal:	Tania, Umme
Altres autors:	Khan, Tanisha
Format:	Thesis
Idioma:	English
Publicat:	Brac University 2023
Matèries:	Biologics Biosimilars Bevacizumab Non-small cell lung cancer Regulatory frameworks Targeted therapy Lungs > Cancer
Accés en línia:	http://hdl.handle.net/10361/18736

Ítems similars

A review on targeted therapies for lung cancer
per: Ashraf, Anushey
Publicat: (2023)

Molecules associated with the development of lung cancer
per: Rahman, Adree, et al.
Publicat: (2023)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
per: Paul, Pulock
Publicat: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
per: Jeba, Joynob
Publicat: (2017)

Potential of liposomes for the treatment of lung cancer- a review
per: Mim, Shanzida
Publicat: (2023)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
per: Rahman, Tasnim
Publicat: (2024)

Biosimilar in lymphoma treatment
per: Tanisha, Mehrin Haque
Publicat: (2021)

A review on recent advances in drugs for lung cancer treatment
per: Noor, Fouzia
Publicat: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
per: Hoque, Ismoth Ara
Publicat: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
per: Razna, Amrin Islam
Publicat: (2019)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
per: Bristy, Israt Zerin
Publicat: (2021)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
per: Shabnam, Musharrat
Publicat: (2018)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
per: Pial, Sazia Afrin
Publicat: (2018)

Immunotherapy in the Management of Lung Cancer
per: Tasnim, Humayra
Publicat: (2022)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
per: Zangmo, Thinley
Publicat: (2024)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
per: Nandy, Aditi
Publicat: (2022)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
per: Flora, Sanzida Alam
Publicat: (2024)

Targeted therapeutic options in the treatment of Breast Cancer
per: Alam, Kazi Tasnuva
Publicat: (2022)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
per: Das, Reshita
Publicat: (2024)

Concepts and challenges of biosimilars to mitigate the oncology drug expenses
per: Tania, Umme
Publicat: (2021)

Lung cancer detection and classification using machine learning
per: Arefin, Mahbubul, et al.
Publicat: (2023)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
per: Mukti, Roushney Fatima, et al.
Publicat: (2016)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
per: Karim, Samia Binte
Publicat: (2024)

Stem cells as therapeutic carrier in cancer treatment
per: Anika, Mysha Yeasmin
Publicat: (2022)

SIRT6 and cancer stem cells: is there any implication?
per: Sarker, Tanosi
Publicat: (2022)

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
per: Nawar, Anika
Publicat: (2019)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
per: Nahar, Kamrun
Publicat: (2023)

Biologics and Biosimilars as Treatment Options for Psoriasis
per: Moya, Amena Khatun
Publicat: (2023)

Targeting BRAFV600E in the treatment of CRC
per: Roja, Mashwiyat Samrin
Publicat: (2024)

Molecular biology of cancer : mechanisms, targets, and therapeutics /
per: Pecorino, Lauren
Publicat: (2012)

Trend in approval of targeted biologics in the last two decades
per: Siddika, Khadiza
Publicat: (2024)

Dendritic cell vaccine for the treatment of cancer
per: Haque, Tanzila
Publicat: (2023)

Biosimilars: A revolution for biologics in the pharmaceutical industry
per: Moreino, Shannon Sherwin
Publicat: (2018)

Stem cell in cancer disease cure vs cause
per: Chowdhury, Marisha Mansur
Publicat: (2023)

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results
per: F. S. Amaral, André, et al.
Publicat: (2017)

RIPK pathway, as a potential target, for cancer treatment - a review
per: Jahan, Nusrat
Publicat: (2024)

Recent advances in Cancer treatment targeting autophagy and future aspects
per: Emon, Kamrul Hasan
Publicat: (2022)

CAR-T cell Therapy in B-cell Lymphoma
per: Faruk, Asef
Publicat: (2020)

Biosimilar insulins: a potential option in the treatment of Diabetes
per: Tabassum, Turana
Publicat: (2022)

Semantic segmentation with attention dense U-net for lung extraction from X-ray images
per: Auvy, Akib Al Mahmud, et al.
Publicat: (2023)